Indication
Myelodysplastic Syndrome/Acute Myeloid Leukemia
3 clinical trials
4 products
2 drugs
Clinical trial
A Phase Ib Investigation of the LSD1 Inhibitor Iadademstat (ORY-1001) in Combination With Azacitidine and Venetoclax in Newly Diagnosed AMLStatus: Not yet recruiting, Estimated PCD: 2026-03-08
Product
AzacitidineProduct
IadademstatProduct
VenetoclaxClinical trial
A Randomized Phase II/III Study of Azacitidine in Combination With Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination With Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)Status: Active (not recruiting), Estimated PCD: 2015-06-01
Drug
lenalidomideProduct
VorinostatClinical trial
A Phase 1b Study of the Multi-Kinase Inhibitor Regorafenib in Combination With the BCL-2 Inhibitor Venetoclax Plus Azacitidine in Patients With Relapsed/Refractory Acute Myeloid LeukemiaStatus: Not yet recruiting, Estimated PCD: 2027-02-17
Drug
Regorafenib